STOCK TITAN
  1. Home
  2. Financials
  3. CNBX
  4. EPS (Diluted)

CNBX Pharms (CNBX) EPS by Year

CNBX

CNBX Pharms earned $0.00 per diluted share in fiscal year 2025. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters CNBX Pharms has filed alongside them.

FY2025 annual
EPS (Diluted) $0.00
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNBX EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)$0.00-$0.02+95.2%-$0.42+88.3%-$3.59-$0.02N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

CNBX EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)$0.00$0.00$0.00$0.00$0.00$0.00$0.00+83.3%$0.00-100.0%$0.00-$0.01-$0.01$0.36

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More CNBX Pharms financials

Frequently Asked Questions

What was CNBX Pharms's diluted earnings per share in fiscal year 2025?

CNBX Pharms earned $0.00 per diluted share in fiscal year 2025.

What was CNBX Pharms's diluted earnings per share in the most recent quarter?

CNBX Pharms (CNBX) reported $0.00 in diluted earnings per share in Q3 2026.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CNBX Pharms (CNBX) reported on that line in every period on record.